vTv Therapeutics to Participate in the 38th Annual ROTH Conference [Yahoo! Finance]
vTv Therapeutics Inc. - Class A (VTVT)
Last vtv therapeutics inc. - class a earnings: 7/31 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vtvtherapeutics.com
Company Research
Source: Yahoo! Finance
company focused on the development of cadisegliatin , a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today announced that management will participate in a fireside chat and conduct 1x1 investor meetings at the 38 th Annual ROTH Conference, which is being held March 22-24, 2026, in Dana Point, CA. th Annual ROTH Conference Format: Fireside chat and 1x1 investor meetings Date: Monday, March 23, 2026 Time: 10:00 AM PDT Webcast Link A live webcast of the fireside chat will be available on the Media & Events section of the Company's website at vtvtherapeutics.com . A replay of the webcast will be available following the event. About vTv Therapeutics vTv Therapeutics is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. vTv's clinical pipeline is led by cadisegl
Show less
Read more
Impact Snapshot
Event Time:
VTVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTVT alerts
High impacting vTv Therapeutics Inc. - Class A news events
Weekly update
A roundup of the hottest topics
VTVT
News
- vTv Therapeutics to Participate in the 38th Annual ROTH ConferenceGlobeNewswire
- vTv Therapeutics (VTVT) was upgraded by Evercore Inc to "strong-buy".MarketBeat
- vTv Therapeutics (VTVT) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=VTVT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" tMarketBeat
- vTv Therapeutics (VTVT) is now covered by Evercore Inc. They set an "outperform" rating on the stock.MarketBeat
- vTv Therapeutics (VTVT) had its "buy" rating reaffirmed by BTIG Research.MarketBeat
VTVT
Earnings
- 5/15/25 - Miss
VTVT
Sec Filings
- 3/10/26 - Form 8-K
- 3/10/26 - Form 8-K
- 3/10/26 - Form 10-K
- VTVT's page on the SEC website